Mineralys Therapeutics Inc.
Clinical trials sponsored by Mineralys Therapeutics Inc., explained in plain language.
-
New pill could help millions with stubborn high blood pressure
Disease control CompletedThis study tested a new drug called lorundrostat in 285 adults whose high blood pressure remained uncontrolled despite taking 2 to 5 standard medications. Participants received either lorundrostat or a placebo added to their current regimen. The goal was to see if the drug could …
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 06:18 UTC
-
New pill could tame resistant high blood pressure
Disease control CompletedThis study tested a new drug called lorundrostat in 1083 adults whose high blood pressure was not controlled despite taking 2 to 5 different medications. The goal was to see if adding lorundrostat could safely lower blood pressure more than a placebo. Participants took either the…
Phase: PHASE3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 06:18 UTC
-
New pill could ease sleep apnea and lower blood pressure at once
Disease control CompletedThis study tested a daily pill called lorundrostat in 48 adults with moderate-to-severe sleep apnea and high blood pressure. The goal was to see if the drug could reduce breathing pauses during sleep and lower nighttime blood pressure. Participants were randomly assigned to recei…
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC